Portfolio – Spindletop Capital

INVESTMENT PORTFOLIO

OUR PORTFOLIO

At Spindletop Capital, we emphasize relationships and build long-term partnerships with extraordinary management teams. We are sought after by entrepreneurs and syndicate investment partners for our industry expertise, our financial expertise and our proprietary Texas resources. We support entrepreneurs in every aspect of their business—from strategy and recruiting to operational improvements.

Sanova is a leading physician-owned, physician-led multistate dermatology practice providing comprehensive cosmetic, medical, and surgical dermatology services.

A premier medical group providing personalized treatment to patients who suffer from chronic discomfort. TPA focuses on providing a multidisciplinary non-opioid approach to Pain Management including physical therapy, behavioral, and minimally invasive surgery.

Bioventus is a global leader of innovations for active healing. Through a combination of internal product development, product/business acquisition, and distribution agreements, we will bring to market products which address a growing need for clinically effective, cost efficient, minimally invasive medical treatments, that engage and enhance the body’s natural healing processes.

HNI provides a tech-enabled solution (and employs over 1,200 providers) for primary care, hospital medicine, and post-acute care, which optimizes health system performance and enables the transition to value-based care

Castle Biosciences offers diagnostic tests that provide actionable, tumor-specific information for improved treatment decisions and patient outcomes. Their innovative tests for skin cancers, uveal melanoma, Barrett’s esophagus and mental health conditions provide personalized, clinically actionable information to clinicians and patients to guide treatment decisions and improve health outcomes.

The leading oncology care solution that is powerful for practices, flexible for staff, and gives patients a personalized and secure digital experience outside of the clinic. Navigating Cancer empowers patients, improves health outcomes, and advances care delivery for everyone impacted by cancer.

Edgemont Pharmaceuticals focuses on the fields of psychiatry/neuroscience and develops novel drug formulations and therapies to improve patient care.

SELECT LEGACY INVESTMENTS

Select Legacy Investments include investment sourced, led, and/or managed by one or more Spindletop Capital Managing Directors during his or her service at a prior investment firm. Past performance is not necessarily indicative of future results.

IDEV Technologies is a medical device company focused on the development of products for endovascular and interventional applications.

Accumetrics is committed to advancing medical understanding of platelet function and enhancing quality of care for patients receiving anti platelet therapies by providing industry-leading and widely accessible diagnostic tests for rapid platelet function assessment.

Develop therapeutic peptide-based medical devices to improved bone and soft tissue repair.

OsteoBiologics engages in the development and manufacture of bioabsordable polymeric scaffolds, films, and related instrumentations.

Advancing the treatment of ear, nose and throat treatments through evidence-based innovation. Commercialize innovative treatment benefiting 29 million sinusitis patients in the US.

Inhibetex, a clinical-stage biopharmaceutical company dedicated to the development of innovative products that can treat or prevent serious infections, primarily focuses on the development of nucleotide/nucleoside analogs for the treatment hepatitis C Virus (HCV).

Glycomimetics is a clinical-stage biotechnology company discovering and developing glycobiology-based therapies for cancers.

Develops and markets drug-device products for the repair of orthopedic injuries to bond, cartilage, ligaments, and tendons.

Medical Aesthetics company that produced injectable implant products used in minimally invasive soft tissue augmentations procedures.

Helped bring the market nobel drug inhalation technology to help 2.4 million Schizophrenia and 5.7 million bipolar patients in the US.

Brought to market treatment improving and extended life for the 40,000+ childrens (and adults) living with Cystic Fibrosis patients in the US.

Develops and manufactures implantable spine systems and instruments for orthopedics and neurosurgery.

Insite Vision develops therapeautic products for common eye problems: infection, pain and inflammation and occulalr surgery and glaucoma.

Alaunos is a clinical-stage oncology-focused cell therapy company, focus on developing T-Cell receptor (TCR) therapies.

Cameron Health, a medical device company, develops, manufactures and distributes implantable defibrillators.

INVESTMENT PORTFOLIO

OUR PORTFOLIO

Sanova Dermatology

Tri City Pain Associates

Bioventus

HNI Healthcare

Castle Biosciences

Navigating Cancer

Edgemont Pharmaceuticals

SELECT LEGACY INVESTMENTS

IDEV Technologies

Accumetrics

BioSet

OsteoBiologics

Intersect

Inhibitex

Glycomimetics

Biomimetic Therapeutics

BioForm Medical

Alexza Pharmaceuticals

CORUS

LDR Medical

Insite Vision

Ziopharm Oncology

Cameron Medical

Quick Links

Strategy

Contact Info.